3.4.21.7 Aprotinin augments binding of hepatocytes from mice to immobilized plasmin 685347 3.4.21.7 arachidonate - 686689 3.4.21.7 Blood serum 2.0% equine serum increases plasmin activity by ca.50% when assayed with N-Suc-L-Ala-L-Phe-L-Lys-7-amido-4-methyl-coumarin in milk 668957 3.4.21.7 Efb protein plasminogen bound to Efb protein is converted to plasmin 732706 3.4.21.7 Factor IXa regulates plasmin-catalyzed factor VIIIa inactivation 685399 3.4.21.7 fragment X profibrinolytic effect with plasmin. Rates of plasmin formation increase with increasing fragment X concentrations. Plasmin degrades clots containing fragment X more rapidly than fibrin clots 685074 3.4.21.7 high molecular weight urokinase-type plasminogen activator induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes 688153 3.4.21.7 low molecular weight urokinase-type plasminogen activator induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes 688153 3.4.21.7 additional information activation of a low concentration of plasminogen by cell-associated plasminogen activators produces sufficient active plasmin to rapidly and efficiently process pro-brain-derived neurotrophic factor in the pericellular environment 686775 3.4.21.7 additional information ATF-urokinase-type plasminogen activator causes little, if any, increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes 688153